Xenon Pharmaceuticals (XENE)
(Delayed Data from NSDQ)
$43.00 USD
+0.34 (0.80%)
Updated Mar 27, 2024 04:00 PM ET
After-Market: $42.96 -0.04 (-0.09%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/14/2024
Time: -- |
3/2024 | $-0.69 | 0.00% |
Earnings Summary
For their last quarter, Xenon Pharmaceuticals (XENE) reported earnings of -$0.64 per share, beating the Zacks Consensus Estimate of $-0.76 per share. This reflects a positive earnings surprise of 15.79%. Look out for XENE's next earnings release expected on May 14, 2024. For the next earning release, we expect the company to report earnings of -$0.69 per share, reflecting a year-over-year decrease of 9.52%.
Earnings History
Price & Consensus
Zacks News for XENE
Here's Why You Should Add Xenon (XENE) to Your Portfolio Now
XENE: What are Zacks experts saying now?
Zacks Private Portfolio Services